Oocyte Donation
8
2
2
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.5%
1 terminated out of 8 trials
80.0%
-6.5% vs benchmark
25%
2 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)
Preeclampsia and Defective Placentation in Oocyte Donation: Importance of HLA-C and KIR
Luteal Phase Ovarian Stimulation With Follitropin Delta and Dydrogesterone
What Are the Predictive Factors for Preeclampsia in Oocyte Recipients? - PREROVE
Transfer Strategy in an Oocyte Donation Programme
Corifollitropin Alfa on D5 Versus D7 After Contraceptive Pill
Immunogenicity of Repeated Follicle Stimulating Hormone (FSH) Stimulation Cycles
Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation